Similarly, Sun and colleagues reported that SFN-mediated activation of Nrf2 signaling can prevent cardiomyopathy in mice with streptozotocin-induced hyperglycemia in an AMPKα2-dependent manner. The gene discussed is NFE2L2; the disease is cardiomyopathy.